LATE-BREAKING ABSTRACT: Burden and risk factors of chronic bronchitis - results from the Burden of Obstructive Lung Disease (BOLD) Study

F. Mejza, D. Obaseki, L. Gnatiuc, S. Buist, W. Vollmer, B. Lamprecht, P. Nastalek, E. Nizankowska-Mogilnicka, K. Sladek, P. Burney (Krakow, Poland; Ile-Ife, Nigeria; London, United Kingdom; Portland, United States Of America; Salzburg, Austria)

Source: International Congress 2014 – Epidemiology of asthma
Session: Epidemiology of asthma
Session type: Thematic Poster Session
Number: 4082
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Mejza, D. Obaseki, L. Gnatiuc, S. Buist, W. Vollmer, B. Lamprecht, P. Nastalek, E. Nizankowska-Mogilnicka, K. Sladek, P. Burney (Krakow, Poland; Ile-Ife, Nigeria; London, United Kingdom; Portland, United States Of America; Salzburg, Austria). LATE-BREAKING ABSTRACT: Burden and risk factors of chronic bronchitis - results from the Burden of Obstructive Lung Disease (BOLD) Study. Eur Respir J 2014; 44: Suppl. 58, 4082

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Poverty and chronic airflow obstruction in the multinational Burden of Obstructive Lung Disease (BOLD) study: An update
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


COPD prevalence in Portugal. The Burden of Obstructive Lung Disease study (BOLD)
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Unemployment in chronic airflow obstruction (CAO) around the world: Results from the Burden of Obstructive Lung Disease (BOLD) study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

Sexuality in Chronic Obstructive Pulmonary Disease (SEXY COPD)
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020

The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019


Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021


Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018

Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD
Source: Eur Respir J 2014; 44: 1177-1187
Year: 2014



Case-finding options for COPD: results from the Burden of Obstructive Lung Disease Study
Source: Eur Respir J 2013; 41: 548-555
Year: 2013



“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018

Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Undiagnosed COPD in adults 40 years and older: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021

Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir Rev 2009; 18: 133
Year: 2009


Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019

Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021


Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
Source: International Congress 2019 – More and more COPD
Year: 2019

Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020


Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
Source: Eur Respir J , 49 (3) 1700214; DOI: 10.1183/13993003.00214-2017
Year: 2017



Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Source: Eur Respir J, 53 (5) 1900164; 10.1183/13993003.00164-2019
Year: 2019